NSAID with proton pump inhibitor combination

This page covers all NSAID with proton pump inhibitor combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting COX-1/COX-2 (naproxen); H+/K+-ATPase (esomeprazole).

Targets

COX-1/COX-2 (naproxen); H+/K+-ATPase (esomeprazole)

Marketed (4)

• Naproxen-esomeprazole · University of Sao Paulo · Rheumatology / Gastroenterology
  Naproxen-esomeprazole combines a nonsteroidal anti-inflammatory drug (NSAID) with a proton pump inhibitor to reduce inflammation and pain while protecting the stomach from NSAID-induced ulcers.
• VIMOVO 375/20 · Amgen · Rheumatology / Pain Management
  VIMOVO combines naproxen (an NSAID) with esomeprazole (a proton pump inhibitor) to reduce pain and inflammation while protecting the stomach from NSAID-induced ulcers.
• VIMOVO 250/20 · Amgen · Rheumatology / Pain Management
  VIMOVO combines naproxen (an NSAID) with esomeprazole (a proton pump inhibitor) to reduce pain and inflammation while protecting the stomach from NSAID-induced ulcers.
• VIMOVO 500/20 · Amgen · Rheumatology / Pain Management
  VIMOVO combines naproxen (an NSAID) with esomeprazole (a proton pump inhibitor) to reduce pain and inflammation while protecting the stomach from NSAID-induced ulcers.